Los Angeles (PRWEB) March 05, 2014
MitoSynergy is proud to announce that they are in the final stages of double-blinded clinical studies for their proprietary Cunermuspir complex, a copper b3 chelate. This exclusive Cunermuspir complex is at the core of the MitoSynergy product line.
Natural Products Expo West 2014 attendees will have the opportunity learn more about the world’s first copper B3 chelate at the MitoSynergy booth, and can sign up to receive the final published studies. The clinical trials tested Cunermuspir for its ability to support increased mental clarity, increased energy, and ability to help reduce discomfort. Conducting the test is KGK Synergize, a clinical research company located in London, Ontario.
“Since its launch in 2013, MitoSynergy has seen phenomenal results from consumer feedback,” said Charlie Barker, CEO, President and co-founder of MitoSynergy. “We are confident that the clinical trials will show results to match and substantiate these positive testimonials from our customers.”
Cunermuspir maximus, which is MitoSynergy’s patent pending proprietary amino acid copper chelate, which is an ideal fit for the world’s first copper liposome, is also in the final stages of clinical trials.
MitoSynergy invites Expo West attendees to visit their booth and sign up to receive published clinical results at the end of the study. They will be at booth #896 at Natural Products Expo West 2014 from March 7, 2014 to March 9, 2014, at the Anaheim Convention Center in Anaheim, California.
For more information about MitoSynergy, please visit http://www.MitoSynergy.com.
MitoSynergy is a nutritional supplement company whose core products contain the Cunermuspir complex, a proprietary blend of copper and b3 that may improve energy, reduce discomfort, and aid mental clarity. Cunermuspir is currently in final stages of double blinded clinical studies. MitoSynergy is showcasing their entire product line at booth #896 at Natural Products Expo West 2014 from Friday, March 7, 2014 to Sunday, March 9, 2014 at the Anaheim Convention Center in Anaheim, CA.
About KGK Synergize, Inc.
KGK Synergize is comprised of two divisions: Contract Research Services and Product Development, offering a wide range of services. The company conducts human clinical trials for the health nutrition industry and specializes in developing clinical studies that meet FDA/FTC and Health Canada regulations. KGK Synergize also offers clinical trial services to assist companies in substantiating claims and provides comprehensive final reports to be submitted to regulatory agencies. Clients know that they can trust the scientific excellence, unparalleled service and reputation for quality results that have made KGK Synergize a leader in the North American nutraceutical industry.